WHO ICTRP trial
Bioequivalence study of levothyroxine 100 mcg tablets
IRCT20130626013776N113 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20130626013776N113 |
|---|---|
| Public title | Bioequivalence study of levothyroxine 100 mcg tablets |
| Scientific title | A study to compare the relative bioavailability of Alborz Zagros and MerckSerono 100 mcg tablet formulations of levothyroxine in 24 healthy adult volunteers under fasting conditions |
| Primary sponsor | Alborroz Zags Pharmaceutical Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | Bioequivalence |
| Countries | Iran (Islamic Republic of) |
| Conditions | .. |
| Interventions | Intervention 1: Intervention group 1: Oral administration of a single 600 mcg dose of levothyroxine manufactured by Alborz Zagros to healthy volunteers under fasting condition in the morning of the experiment day. Intervention 2… |
| Registration date | Dec 18, 2023 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: